#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#

The Toll-Like Receptor Gene Family Is Integrated into Human DNA Damage and p53 Networks


In recent years the functions that the p53 tumor suppressor plays in human biology have been greatly extended beyond “guardian of the genome.” Our studies of promoter response element sequences targeted by the p53 master regulatory transcription factor suggest a general role for this DNA damage and stress-responsive regulator in the control of human Toll-like receptor (TLR) gene expression. The TLR gene family mediates innate immunity to a wide variety of pathogenic threats through recognition of conserved pathogen-associated molecular motifs. Using primary human immune cells, we have examined expression of the entire TLR gene family following exposure to anti-cancer agents that induce the p53 network. Expression of all TLR genes, TLR1 to TLR10, in blood lymphocytes and alveolar macrophages from healthy volunteers can be induced by DNA metabolic stressors. However, there is considerable inter-individual variability. Most of the TLR genes respond to p53 via canonical as well as noncanonical promoter binding sites. Importantly, the integration of the TLR gene family into the p53 network is unique to primates, a recurrent theme raised for other gene families in our previous studies. Furthermore, a polymorphism in a TLR8 response element provides the first human example of a p53 target sequence specifically responsible for endogenous gene induction. These findings—demonstrating that the human innate immune system, including downstream induction of cytokines, can be modulated by DNA metabolic stress—have many implications for health and disease, as well as for understanding the evolution of damage and p53 responsive networks.


Vyšlo v časopise: The Toll-Like Receptor Gene Family Is Integrated into Human DNA Damage and p53 Networks. PLoS Genet 7(3): e32767. doi:10.1371/journal.pgen.1001360
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pgen.1001360

Souhrn

In recent years the functions that the p53 tumor suppressor plays in human biology have been greatly extended beyond “guardian of the genome.” Our studies of promoter response element sequences targeted by the p53 master regulatory transcription factor suggest a general role for this DNA damage and stress-responsive regulator in the control of human Toll-like receptor (TLR) gene expression. The TLR gene family mediates innate immunity to a wide variety of pathogenic threats through recognition of conserved pathogen-associated molecular motifs. Using primary human immune cells, we have examined expression of the entire TLR gene family following exposure to anti-cancer agents that induce the p53 network. Expression of all TLR genes, TLR1 to TLR10, in blood lymphocytes and alveolar macrophages from healthy volunteers can be induced by DNA metabolic stressors. However, there is considerable inter-individual variability. Most of the TLR genes respond to p53 via canonical as well as noncanonical promoter binding sites. Importantly, the integration of the TLR gene family into the p53 network is unique to primates, a recurrent theme raised for other gene families in our previous studies. Furthermore, a polymorphism in a TLR8 response element provides the first human example of a p53 target sequence specifically responsible for endogenous gene induction. These findings—demonstrating that the human innate immune system, including downstream induction of cytokines, can be modulated by DNA metabolic stress—have many implications for health and disease, as well as for understanding the evolution of damage and p53 responsive networks.


Zdroje

1. HeL

HeX

LoweSW

HannonGJ

2007 microRNAs join the p53 network–another piece in the tumour-suppression puzzle. Nat Rev Cancer 7 819 822

2. HuarteM

GuttmanM

FeldserD

GarberM

KoziolMJ

2010 A large intergenic noncoding RNA induced by p53 mediates global gene repression in the p53 response. Cell 142 409 419

3. JordanJJ

MenendezD

IngaA

NourredineM

BellD

2008 Noncanonical DNA motifs as transactivation targets by wild type and mutant p53. PLoS Genet 4 e1000104 doi:10.1371/journal.pgen.1000104

4. NoureddineMA

MenendezD

CampbellMR

BandeleOJ

HorvathMM

2009 Probing the functional impact of sequence variation on p53-DNA interactions using a novel microsphere assay for protein-DNA binding with human cell extracts. PLoS Genet 5 e1000462 doi:10.1371/journal.pgen.1000462

5. MenendezD

IngaA

ResnickMA

2010 Estrogen receptor acting in cis enhances WT and mutant p53 transactivation at canonical and noncanonical p53 target sequences. Proc Natl Acad Sci U S A 107 1500 1505

6. MenendezD

IngaA

ResnickMA

2009 The expanding universe of p53 targets. Nat Rev Cancer 9 724 737

7. JeggaAG

IngaA

MenendezD

AronowBJ

ResnickMA

2008 Functional evolution of the p53 regulatory network through its target response elements. Proc Natl Acad Sci U S A 105 944 949

8. TomsoDJ

IngaA

MenendezD

PittmanGS

CampbellMR

2005 Functionally distinct polymorphic sequences in the human genome that are targets for p53 transactivation. Proc Natl Acad Sci U S A 102 6431 6436

9. TauraM

EgumaA

SuicoMA

ShutoT

KogaT

2008 p53 regulates Toll-like receptor 3 expression and function in human epithelial cell lines. Mol Cell Biol 28 6557 6567

10. PalmNW

MedzhitovR

2009 Pattern recognition receptors and control of adaptive immunity. Immunol Rev 227 221 233

11. BauerS

MullerT

HammS

2009 Pattern recognition by Toll-like receptors. Adv Exp Med Biol 653 15 34

12. GarantziotisS

HollingsworthJW

ZaasAK

SchwartzDA

2008 The effect of toll-like receptors and toll-like receptor genetics in human disease. Annu Rev Med 59 343 359

13. HennessyEJ

ParkerAE

O'NeillLA

2010 Targeting Toll-like receptors: emerging therapeutics? Nat Rev Drug Discov 9 293 307

14. IwasakiA

MedzhitovR

2010 Regulation of adaptive immunity by the innate immune system. Science 327 291 295

15. ArmstrongL

MedfordAR

HunterKJ

UppingtonKM

MillarAB

2004 Differential expression of Toll-like receptor (TLR)-2 and TLR-4 on monocytes in human sepsis. Clin Exp Immunol 136 312 319

16. Komai-KomaM

JonesL

OggGS

XuD

LiewFY

2004 TLR2 is expressed on activated T cells as a costimulatory receptor. Proc Natl Acad Sci U S A 101 3029 3034

17. HarterL

MicaL

StockerR

TrentzO

KeelM

2004 Increased expression of toll-like receptor-2 and -4 on leukocytes from patients with sepsis. Shock 22 403 409

18. HayashiF

MeansTK

LusterAD

2003 Toll-like receptors stimulate human neutrophil function. Blood 102 2660 2669

19. Kurt-JonesEA

MandellL

WhitneyC

PadgettA

GosselinK

2002 Role of toll-like receptor 2 (TLR2) in neutrophil activation: GM-CSF enhances TLR2 expression and TLR2-mediated interleukin 8 responses in neutrophils. Blood 100 1860 1868

20. MuzioM

BosisioD

PolentaruttiN

D'AmicoG

StoppacciaroA

2000 Differential expression and regulation of toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J Immunol 164 5998 6004

21. CorreaCR

CheungVG

2004 Genetic variation in radiation-induced expression phenotypes. Am J Hum Genet 75 885 890

22. LevineAJ

1997 p53, the cellular gatekeeper for growth and division. Cell 88 323 331

23. VassilevLT

VuBT

GravesB

CarvajalD

PodlaskiF

2004 In vivo activation of the p53 pathway by small-molecule antagonists of MDM2. Science 303 844 848

24. KomarovPG

KomarovaEA

KondratovRV

Christov-TselkovK

CoonJS

1999 A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. Science 285 1733 1737

25. el-DeiryWS

KernSE

PietenpolJA

KinzlerKW

VogelsteinB

1992 Definition of a consensus binding site for p53. Nat Genet 1 45 49

26. RileyT

SontagE

ChenP

LevineA

2008 Transcriptional control of human p53-regulated genes. Nat Rev Mol Cell Biol 9 402 412

27. MenendezD

IngaA

ResnickMA

2006 The biological impact of the human master regulator p53 can be altered by mutations that change the spectrum and expression of its target genes. Mol Cell Biol 26 2297 2308

28. DesleeG

WoodsJC

MooreC

ConradiSH

GieradaDS

2009 Oxidative damage to nucleic acids in severe emphysema. Chest 135 965 974

29. IshidaT

HironoY

YoshikawaK

HuteiY

MiyagawaM

2009 Inhibition of immunological function mediated DNA damage of alveolar macrophages caused by cigarette smoke in mice. Inhal Toxicol 21 1229 1235

30. MengZ

ZhangQ

2007 Damage effects of dust storm PM2.5 on DNA in alveolar macrophages and lung cells of rats. Food Chem Toxicol 45 1368 1374

31. PasareC

MedzhitovR

2005 Control of B-cell responses by Toll-like receptors. Nature 438 364 368

32. SchnareM

BartonGM

HoltAC

TakedaK

AkiraS

2001 Toll-like receptors control activation of adaptive immune responses. Nat Immunol 2 947 950

33. EspinosaJM

VerdunRE

EmersonBM

2003 p53 functions through stress- and promoter-specific recruitment of transcription initiation components before and after DNA damage. Mol Cell 12 1015 1027

34. GomesNP

EspinosaJM

2010 Differential regulation of p53 target genes: it's (core promoter) elementary. Genes Dev 24 111 114

35. MenendezD

KrysiakO

IngaA

KrysiakB

ResnickMA

2006 A SNP in the flt-1 promoter integrates the VEGF system into the p53 transcriptional network. Proc Natl Acad Sci U S A 103 1406 1411

36. YanJ

MenendezD

YangXP

ResnickMA

JettenAM

2009 A regulatory loop composed of RAP80-HDM2-p53 provides RAP80-enhanced p53 degradation by HDM2 in response to DNA damage. J Biol Chem 284 19280 19289

37. HussainSP

AmstadP

HeP

RoblesA

LupoldS

2004 p53-induced up-regulation of MnSOD and GPx but not catalase increases oxidative stress and apoptosis. Cancer Res 64 2350 2356

38. LiuB

ChenY

St ClairDK

2008 ROS and p53: a versatile partnership. Free Radic Biol Med 44 1529 1535

39. JiangD

LiangJ

FanJ

YuS

ChenS

2005 Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat Med 11 1173 1179

40. ZhangQ

RaoofM

ChenY

SumiY

SursalT

2010 Circulating mitochondrial DAMPs cause inflammatory responses to injury. Nature 464 104 107

41. BurdelyaLG

KrivokrysenkoVI

TallantTC

StromE

GleibermanAS

2008 An agonist of toll-like receptor 5 has radioprotective activity in mouse and primate models. Science 320 226 230

42. Cherfils-ViciniJ

PlatonovaS

GillardM

LauransL

ValidireP

2010 Triggering of TLR7 and TLR8 expressed by human lung cancer cells induces cell survival and chemoresistance. J Clin Invest 120 1285 1297

43. WestbrookAM

WeiB

BraunJ

SchiestlRH

2009 Intestinal mucosal inflammation leads to systemic genotoxicity in mice. Cancer Res 69 4827 4834

44. ShaoL

FujiiH

ColmegnaI

OishiH

GoronzyJJ

2009 Deficiency of the DNA repair enzyme ATM in rheumatoid arthritis. J Exp Med 206 1435 1449

45. KanzlerH

BarratFJ

HesselEM

CoffmanRL

2007 Therapeutic targeting of innate immunity with Toll-like receptor agonists and antagonists. Nat Med 13 552 559

Štítky
Genetika Reprodukčná medicína

Článok vyšiel v časopise

PLOS Genetics


2011 Číslo 3
Najčítanejšie tento týždeň
Najčítanejšie v tomto čísle
Kurzy

Zvýšte si kvalifikáciu online z pohodlia domova

Aktuální možnosti diagnostiky a léčby litiáz
nový kurz
Autori: MUDr. Tomáš Ürge, PhD.

Všetky kurzy
Prihlásenie
Zabudnuté heslo

Zadajte e-mailovú adresu, s ktorou ste vytvárali účet. Budú Vám na ňu zasielané informácie k nastaveniu nového hesla.

Prihlásenie

Nemáte účet?  Registrujte sa

#ADS_BOTTOM_SCRIPTS#